CYB5D2 displays tumor suppression activities towards cervical cancer
- 1 April 2016
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1862 (4) , 556-565
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81302210)
- Heart and Stroke Foundation (NA6326)
- CIHR (MOP-84381)
This publication has 42 references indexed in Scilit:
- IQGAP2, A candidate tumour suppressor of prostate tumorigenesisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Pgrmc1 (Progesterone Receptor Membrane Component 1) Associates with Epidermal Growth Factor Receptor and Regulates Erlotinib SensitivityJournal of Biological Chemistry, 2010
- Shank-interacting protein–like 1 promotes tumorigenesis via PTEN inhibition in human tumor cellsJournal of Clinical Investigation, 2010
- PTEN inhibits BMI1 function independently of its phosphatase activityMolecular Cancer, 2009
- Different outcome of invasive cervical cancer associated with high‐risk versus intermediate‐risk HPV genotypeInternational Journal of Cancer, 2008
- Characteristics of membrane progestin receptor alpha (mPRα) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actionsFrontiers in Neuroendocrinology, 2008
- The Consensus Coding Sequences of Human Breast and Colorectal CancersScience, 2006
- Iterative Microarray and RNA Interference–Based Interrogation of the Src-Induced Invasive PhenotypeCancer Research, 2005
- Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysisBritish Journal of Cancer, 2003
- Biological activities and molecular targets of the human papillomavirus E7 oncoproteinOncogene, 2001